Orca Bio

Cell Therapy Case Manager

Menlo Park, California, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

The Cell Therapy Case Manager should have 3-5 years of experience in patient case coordination, transplant scheduling, or specialty pharmacy. A proactive mindset and empathy are required for this role.

Responsibilities

The Cell Therapy Case Manager will serve as the central point of contact for treatment centers, managing the patient case journey from order intake to follow-up. This includes receiving orders, verifying documentation, managing scheduling, and coordinating cross-functional activities to ensure a seamless experience. The role involves proactive communication with treatment centers, building trusted relationships with staff, and escalating issues as needed. The Case Manager will also coordinate with internal stakeholders, support field teams, and contribute to the development and refinement of case management processes and SOPs.

Skills

Case Management
Patient Journey Management
Documentation Verification
Scheduling
Cross-functional Coordination
Customer Experience
Process Development
SOP Development
Biotechnology
Cell Therapy
Blood Cancer
Transplant Coordination
Supply Chain Coordination
Commercial Operations

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI